Amneal Recalls Rabeprazole Sodium Tablets for Failed Dissolution Specifications
Amneal Pharmaceuticals is recalling Rabeprazole Sodium Delayed Release Tablets, 20 mg, because the product failed to meet dissolution specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Amneal Pharmaceuticals LLC is recalling Rabeprazole Sodium Delayed Release Tablets, 20 mg, in 30-count and 90-count bottles. The recall was initiated because the product failed to meet dissolution specifications.
The affected product is prescription-only and was manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and distributed by Amneal Pharmaceuticals in Bridgewater, New Jersey. The recall covers 105,215 bottles distributed nationwide within the United States and Puerto Rico.
Consumers should stop using the recalled medication and contact their healthcare provider or pharmacist for a replacement or further instructions.
The recalled product
- Product
- Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65162-0724-03), b) 90-count bottle (NDC 65162-0724-09), Rx Only, Manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad INDIA 382220, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ 08807
- Manufacturer
- Amneal Pharmaceuticals LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 105,215
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: a) AR151324
- AR151322
- AR151325
- Exp. 9/2017
- AR160730A
- AR160731A
- AR160732A
- Exp. 05/2018. b) AR151324
- AR160730B
- 5/2018.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Amneal Pharmaceuticals LLC
See all →- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- SevereMagnesium sulfate pouch recalled as Class I for containing tranexamic acid
FDA (Drugs) · 2026-04-08
- HighAmneal tramadol tablets failed nitrosamine impurity specification at stability
FDA (Drugs) · 2026-04-08
- ModerateSulfamethoxazole and trimethoprim tablets recalled over micro-organism on packaging coil
FDA (Drugs) · 2025-09-10
- ModerateChlorpromazine 25 mg tablets recalled after micro-organism found on packaging coil
FDA (Drugs) · 2025-09-10
Same hazard · failed dissolution
See all →- ModerateNovartis Recalls Diovan Valsartan Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-08-19
- LowSupernus Recalls Trokendi XR Capsules for Failed Dissolution Specifications
FDA (Drugs) · 2026-07-29
- HighAscend amlodipine and olmesartan tablets failed dissolution specifications
FDA (Drugs) · 2026-06-10
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
- HighMajor Pharmaceuticals memantine extended-release capsules fail dissolution specifications
FDA (Drugs) · 2026-04-22